Aqr Capital Management LLC Viking Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 463,529 shares of VKTX stock, worth $19.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

463,529

Previous 68,070 580.96%

Holding current value

$19.6 Million

Previous $3.61 Million 713.36%

% of portfolio

0.04%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $19.7 Million - $27.9 Million	395,459 Added 580.96%	463,529 $29.3 Million
Q2 2024 Aug 14, 2024	BUY	$47.39 - $80.2 $1.34 Million - $2.26 Million	28,180 Added 70.64%	68,070 $3.61 Million
Q1 2024 May 15, 2024	SELL	$17.4 - $94.5 $131,700 - $715,270	-7,569 Reduced 15.95%	39,890 $3.27 Million
Q4 2023 Feb 14, 2024	SELL	$9.24 - $19.64 $75,804 - $161,126	-8,204 Reduced 14.74%	47,459 $883,000
Q3 2023 Nov 14, 2023	BUY	$10.92 - $16.0 $264,984 - $388,256	24,266 Added 77.29%	55,663 $616,000
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $465,931 - $778,331	31,397 New	31,397 $508,000
Q2 2022 Aug 15, 2022	BUY	$2.11 - $3.15 $165,489 - $247,057	78,431 Added 178.56%	122,356 $354,000
Q1 2022 May 16, 2022	BUY	$3.0 - $4.88 $131,775 - $214,354	43,925 New	43,925 $132,000
Q3 2019 Nov 14, 2019	SELL	$6.55 - $8.6 $216,844 - $284,711	-33,106 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.67 - $10.63 $1,580 - $2,189	206 Added 0.63%	33,106 $275,000
Q1 2019 May 14, 2019	SELL	$7.58 - $9.94 $9,520 - $12,484	-1,256 Reduced 3.68%	32,900 $327,000
Q4 2018 Feb 14, 2019	SELL	$7.16 - $16.21 $191,730 - $434,071	-26,778 Reduced 43.95%	34,156 $261,000
Q3 2018 Nov 15, 2018	SELL	$9.7 - $19.65 $179,857 - $364,350	-18,542 Reduced 23.33%	60,934 $1.06 Million
Q2 2018 Aug 14, 2018	BUY	$3.88 - $12.74 $308,366 - $1.01 Million	79,476 New	79,476 $754,000

Others Institutions Holding VKTX

# of Institutions

473

Shares Held

65.6M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.25B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Viking Therapeutics, Inc. Transaction History